Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Psychedelic Medicine
1.2 Key Market Segments
1.2.1 Psychedelic Medicine Segment by Type
1.2.2 Psychedelic Medicine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Psychedelic Medicine Market Overview
2.1 Global Market Overview
2.1.1 Global Psychedelic Medicine Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Psychedelic Medicine Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Psychedelic Medicine Market Competitive Landscape
3.1 Global Psychedelic Medicine Sales by Manufacturers (2019-2024)
3.2 Global Psychedelic Medicine Revenue Market Share by Manufacturers (2019-2024)
3.3 Psychedelic Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Psychedelic Medicine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Psychedelic Medicine Sales Sites, Area Served, Product Type
3.6 Psychedelic Medicine Market Competitive Situation and Trends
3.6.1 Psychedelic Medicine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Psychedelic Medicine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Psychedelic Medicine Industry Chain Analysis
4.1 Psychedelic Medicine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Psychedelic Medicine Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Psychedelic Medicine Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Psychedelic Medicine Sales Market Share by Type (2019-2024)
6.3 Global Psychedelic Medicine Market Size Market Share by Type (2019-2024)
6.4 Global Psychedelic Medicine Price by Type (2019-2024)
7 Psychedelic Medicine Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Psychedelic Medicine Market Sales by Application (2019-2024)
7.3 Global Psychedelic Medicine Market Size (M USD) by Application (2019-2024)
7.4 Global Psychedelic Medicine Sales Growth Rate by Application (2019-2024)
8 Psychedelic Medicine Market Segmentation by Region
8.1 Global Psychedelic Medicine Sales by Region
8.1.1 Global Psychedelic Medicine Sales by Region
8.1.2 Global Psychedelic Medicine Sales Market Share by Region
8.2 North America
8.2.1 North America Psychedelic Medicine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Psychedelic Medicine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Psychedelic Medicine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Psychedelic Medicine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Psychedelic Medicine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 COMPASS Pathways PLC
9.1.1 COMPASS Pathways PLC Psychedelic Medicine Basic Information
9.1.2 COMPASS Pathways PLC Psychedelic Medicine Product Overview
9.1.3 COMPASS Pathways PLC Psychedelic Medicine Product Market Performance
9.1.4 COMPASS Pathways PLC Business Overview
9.1.5 COMPASS Pathways PLC Psychedelic Medicine SWOT Analysis
9.1.6 COMPASS Pathways PLC Recent Developments
9.2 Pfizer
9.2.1 Pfizer Psychedelic Medicine Basic Information
9.2.2 Pfizer Psychedelic Medicine Product Overview
9.2.3 Pfizer Psychedelic Medicine Product Market Performance
9.2.4 Pfizer Business Overview
9.2.5 Pfizer Psychedelic Medicine SWOT Analysis
9.2.6 Pfizer Recent Developments
9.3 Eli Lilly
9.3.1 Eli Lilly Psychedelic Medicine Basic Information
9.3.2 Eli Lilly Psychedelic Medicine Product Overview
9.3.3 Eli Lilly Psychedelic Medicine Product Market Performance
9.3.4 Eli Lilly Psychedelic Medicine SWOT Analysis
9.3.5 Eli Lilly Business Overview
9.3.6 Eli Lilly Recent Developments
9.4 GlaxoSmithKline
9.4.1 GlaxoSmithKline Psychedelic Medicine Basic Information
9.4.2 GlaxoSmithKline Psychedelic Medicine Product Overview
9.4.3 GlaxoSmithKline Psychedelic Medicine Product Market Performance
9.4.4 GlaxoSmithKline Business Overview
9.4.5 GlaxoSmithKline Recent Developments
9.5 Cybin Inc
9.5.1 Cybin Inc Psychedelic Medicine Basic Information
9.5.2 Cybin Inc Psychedelic Medicine Product Overview
9.5.3 Cybin Inc Psychedelic Medicine Product Market Performance
9.5.4 Cybin Inc Business Overview
9.5.5 Cybin Inc Recent Developments
9.6 Field Trip Health
9.6.1 Field Trip Health Psychedelic Medicine Basic Information
9.6.2 Field Trip Health Psychedelic Medicine Product Overview
9.6.3 Field Trip Health Psychedelic Medicine Product Market Performance
9.6.4 Field Trip Health Business Overview
9.6.5 Field Trip Health Recent Developments
9.7 ATAI Life Sciences
9.7.1 ATAI Life Sciences Psychedelic Medicine Basic Information
9.7.2 ATAI Life Sciences Psychedelic Medicine Product Overview
9.7.3 ATAI Life Sciences Psychedelic Medicine Product Market Performance
9.7.4 ATAI Life Sciences Business Overview
9.7.5 ATAI Life Sciences Recent Developments
9.8 NUMINUS WELLNESS
9.8.1 NUMINUS WELLNESS Psychedelic Medicine Basic Information
9.8.2 NUMINUS WELLNESS Psychedelic Medicine Product Overview
9.8.3 NUMINUS WELLNESS Psychedelic Medicine Product Market Performance
9.8.4 NUMINUS WELLNESS Business Overview
9.8.5 NUMINUS WELLNESS Recent Developments
9.9 MindMed
9.9.1 MindMed Psychedelic Medicine Basic Information
9.9.2 MindMed Psychedelic Medicine Product Overview
9.9.3 MindMed Psychedelic Medicine Product Market Performance
9.9.4 MindMed Business Overview
9.9.5 MindMed Recent Developments
9.10 HAVN Life Sciences
9.10.1 HAVN Life Sciences Psychedelic Medicine Basic Information
9.10.2 HAVN Life Sciences Psychedelic Medicine Product Overview
9.10.3 HAVN Life Sciences Psychedelic Medicine Product Market Performance
9.10.4 HAVN Life Sciences Business Overview
9.10.5 HAVN Life Sciences Recent Developments
9.11 Seelos Therapeutics
9.11.1 Seelos Therapeutics Psychedelic Medicine Basic Information
9.11.2 Seelos Therapeutics Psychedelic Medicine Product Overview
9.11.3 Seelos Therapeutics Psychedelic Medicine Product Market Performance
9.11.4 Seelos Therapeutics Business Overview
9.11.5 Seelos Therapeutics Recent Developments
9.12 Jannsen
9.12.1 Jannsen Psychedelic Medicine Basic Information
9.12.2 Jannsen Psychedelic Medicine Product Overview
9.12.3 Jannsen Psychedelic Medicine Product Market Performance
9.12.4 Jannsen Business Overview
9.12.5 Jannsen Recent Developments
9.13 Acadia Pharmaceuticals
9.13.1 Acadia Pharmaceuticals Psychedelic Medicine Basic Information
9.13.2 Acadia Pharmaceuticals Psychedelic Medicine Product Overview
9.13.3 Acadia Pharmaceuticals Psychedelic Medicine Product Market Performance
9.13.4 Acadia Pharmaceuticals Business Overview
9.13.5 Acadia Pharmaceuticals Recent Developments
9.14 Intellipharmaceutics
9.14.1 Intellipharmaceutics Psychedelic Medicine Basic Information
9.14.2 Intellipharmaceutics Psychedelic Medicine Product Overview
9.14.3 Intellipharmaceutics Psychedelic Medicine Product Market Performance
9.14.4 Intellipharmaceutics Business Overview
9.14.5 Intellipharmaceutics Recent Developments
9.15 Revive Therapeutics
9.15.1 Revive Therapeutics Psychedelic Medicine Basic Information
9.15.2 Revive Therapeutics Psychedelic Medicine Product Overview
9.15.3 Revive Therapeutics Psychedelic Medicine Product Market Performance
9.15.4 Revive Therapeutics Business Overview
9.15.5 Revive Therapeutics Recent Developments
9.16 Mydecine Innovations Group
9.16.1 Mydecine Innovations Group Psychedelic Medicine Basic Information
9.16.2 Mydecine Innovations Group Psychedelic Medicine Product Overview
9.16.3 Mydecine Innovations Group Psychedelic Medicine Product Market Performance
9.16.4 Mydecine Innovations Group Business Overview
9.16.5 Mydecine Innovations Group Recent Developments
9.17 Red Light Holland
9.17.1 Red Light Holland Psychedelic Medicine Basic Information
9.17.2 Red Light Holland Psychedelic Medicine Product Overview
9.17.3 Red Light Holland Psychedelic Medicine Product Market Performance
9.17.4 Red Light Holland Business Overview
9.17.5 Red Light Holland Recent Developments
9.18 Braxia Scientific
9.18.1 Braxia Scientific Psychedelic Medicine Basic Information
9.18.2 Braxia Scientific Psychedelic Medicine Product Overview
9.18.3 Braxia Scientific Psychedelic Medicine Product Market Performance
9.18.4 Braxia Scientific Business Overview
9.18.5 Braxia Scientific Recent Developments
9.19 Mind Cure Health
9.19.1 Mind Cure Health Psychedelic Medicine Basic Information
9.19.2 Mind Cure Health Psychedelic Medicine Product Overview
9.19.3 Mind Cure Health Psychedelic Medicine Product Market Performance
9.19.4 Mind Cure Health Business Overview
9.19.5 Mind Cure Health Recent Developments
9.20 Entheon Biomedical
9.20.1 Entheon Biomedical Psychedelic Medicine Basic Information
9.20.2 Entheon Biomedical Psychedelic Medicine Product Overview
9.20.3 Entheon Biomedical Psychedelic Medicine Product Market Performance
9.20.4 Entheon Biomedical Business Overview
9.20.5 Entheon Biomedical Recent Developments
10 Psychedelic Medicine Market Forecast by Region
10.1 Global Psychedelic Medicine Market Size Forecast
10.2 Global Psychedelic Medicine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Psychedelic Medicine Market Size Forecast by Country
10.2.3 Asia Pacific Psychedelic Medicine Market Size Forecast by Region
10.2.4 South America Psychedelic Medicine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Psychedelic Medicine by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Psychedelic Medicine Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Psychedelic Medicine by Type (2025-2030)
11.1.2 Global Psychedelic Medicine Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Psychedelic Medicine by Type (2025-2030)
11.2 Global Psychedelic Medicine Market Forecast by Application (2025-2030)
11.2.1 Global Psychedelic Medicine Sales (K Units) Forecast by Application
11.2.2 Global Psychedelic Medicine Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
